We are live on ! Find out more
TCM

Tanaka Capital Management Portfolio holdings

AUM $59.9M
This Fund
S&P 500
This Quarter Est. Return
+7.31%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$44.9M
AUM Growth
+$1.21M
Cap. Flow
+$56K
Cap. Flow %
0.12%
Top 10 Hldgs %
63.21%
Holding
54
New
1
Increased
12
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$701K
2
PARAA
Paramount Global Class A
PARAA
+$334K
3
AAPL icon
Apple
AAPL
+$300K
4
PEP icon
PepsiCo
PEP
+$135K
5
BYSI icon
BeyondSpring
BYSI
+$55.8K

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$1.04M
2
INO icon
Inovio Pharmaceuticals
INO
+$688K
3
ADXS
Advaxis Inc
ADXS
+$475K
4
TSEM icon
Tower Semiconductor
TSEM
+$436K
5
SF
Stifel
SF
+$149K

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 21.79%
3 Energy 8.7%
4 Communication Services 7.95%
5 Industrials 7.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$950B
$190K 0.42%
1,994
– –
AMZN icon
27
Amazon
AMZN
$2.48T
$130K 0.29%
2,700
– –
ACN icon
28
Accenture
ACN
$101B
$129K 0.29%
952
-13
-1% -$1.69K
AMAT icon
29
Applied Materials
AMAT
$378B
$129K 0.29%
2,469
+7
+0.3% +$317
META icon
30
Meta Platforms (Facebook)
META
$1.51T
$87K 0.19%
509
– –
ASML icon
31
ASML
ASML
$608B
$49K 0.11%
284
– –
KRFT
32
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$29K 0.06%
376
– –
DIS icon
33
Walt Disney
DIS
$172B
$28K 0.06%
285
– –
MDLZ icon
34
Mondelez International
MDLZ
$80.2B
$24K 0.05%
596
– –
CL icon
35
Colgate-Palmolive
CL
$74.2B
$21K 0.05%
288
– –
NICE icon
36
Nice
NICE
$5.94B
$21K 0.05%
255
– –
CCJ icon
37
Cameco
CCJ
$37.9B
$20K 0.04%
2,100
– –
MNRO icon
38
Monro
MNRO
$537M
$20K 0.04%
365
– –
ASIX icon
39
AdvanSix
ASIX
$551M
$11K 0.02%
286
– –
PG icon
40
Procter & Gamble
PG
$347B
$10K 0.02%
110
– –
HA
41
DELISTED
Hawaiian Holdings, Inc.
HA
$10K 0.02%
275
– –
CHD icon
42
Church & Dwight Co
CHD
$23.7B
$7K 0.02%
140
– –
JNJ icon
43
Johnson & Johnson
JNJ
$643B
$7K 0.02%
50
– –
TRV icon
44
Travelers Companies
TRV
$82.9B
$1K ﹤0.01%
6
– –
AMGN icon
45
Amgen
AMGN
$212B
– –
-115
Closed -$20K
GE icon
46
GE Aerospace
GE
$377B
– –
-149
Closed -$19K
INO icon
47
Inovio Pharmaceuticals
INO
$84.7M
– –
-7,318
Closed -$688K
ADXS
48
DELISTED
Advaxis Inc
ADXS
– –
-4,879
Closed -$475K
1
2

Similar funds

GC
Greencape Capital Melbourne, Australia $59.9M AUM 23.92% 1-Year Est. Return
GCS
Gordian Capital (Singapore) Singapore $59.8M AUM 82.65% 1-Year Est. Return
NI
NCP Inc La Quinta, California $60.1M AUM 39.78% 1-Year Est. Return
CMANY
Capital Management Associates (New York) New York $60.2M AUM 58.47% 1-Year Est. Return
GMC
Gigafund Management Company Austin, Texas $59.4M AUM
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
PCA
PMV Capital Advisers Dallas, Texas $59.3M AUM 19.1% 1-Year Est. Return
ACM
AREX Capital Management New York $60.5M AUM 45.91% 1-Year Est. Return

Tanaka Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Tanaka Capital Management held 54 positions worth $44.9M, up 2.8% from $43.6M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Tanaka Capital Management's Q3 2017 filing shows 1 new, 12 increased, 12 reduced and 4 closed positions. The largest sale was Ionis Pharmaceuticals, an estimated $1.04M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Energy.

  • Tanaka Capital Management added most to Amyris Inc. in Q3 2017, an estimated $701K increase.
  • Tanaka Capital Management's biggest Q3 2017 reduction was Ionis Pharmaceuticals, cutting an estimated $1.04M.
  • Tanaka Capital Management fully exited Inovio Pharmaceuticals in Q3 2017, selling an estimated $688K.
  • Tanaka Capital Management's ten largest holdings make up 63% of its $44.9M portfolio in Q3 2017.
  • Tanaka Capital Management opened 1 new position and closed 4 in Q3 2017.
  • Tanaka Capital Management's portfolio value rose 2.8% quarter-over-quarter to $44.9M.

Based on Tanaka Capital Management's 13F filing for Q3 2017, filed 16 Nov 2017.